These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 8473490
1. Cytokine patterns in the pathogenesis of human leishmaniasis. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F, Modlin RL. J Clin Invest; 1993 Apr; 91(4):1390-5. PubMed ID: 8473490 [Abstract] [Full Text] [Related]
10. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE. Parasite Immunol; 2009 Aug 01; 31(8):423-31. PubMed ID: 19646206 [Abstract] [Full Text] [Related]
11. Mixed cytokine profile during active cutaneous leishmaniasis and in natural resistance. Baratta-Masini A, Teixeira-Carvalho A, Malaquias LC, Mayrink W, Martins-Filho OA, Corrêa-Oliveira R. Front Biosci; 2007 Jan 01; 12():839-49. PubMed ID: 17127341 [Abstract] [Full Text] [Related]
13. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection? Gomes-Silva A, de Cássia Bittar R, Dos Santos Nogueira R, Amato VS, da Silva Mattos M, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM. Clin Exp Immunol; 2007 Sep 01; 149(3):440-4. PubMed ID: 17614975 [Abstract] [Full Text] [Related]
14. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Bomfim G, Nascimento C, Costa J, Carvalho EM, Barral-Netto M, Barral A. Exp Parasitol; 1996 Nov 01; 84(2):188-94. PubMed ID: 8932768 [Abstract] [Full Text] [Related]
15. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Skeiky YA, Benson DR, Guderian JA, Whittle JA, Bacelar O, Carvalho EM, Reed SG. Infect Immun; 1995 Oct 01; 63(10):4105-14. PubMed ID: 7558326 [Abstract] [Full Text] [Related]
20. Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12. Bourreau E, Prévot G, Pradinaud R, Launois P. J Infect Dis; 2001 Mar 15; 183(6):953-9. PubMed ID: 11237813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]